A carregar...

Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non‐Small Cell Lung Cancer in U.S. Community Medical Centers

BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend biomarker testing as the first step in the management of patients with advanced non‐small cell lung cancer (aNSCLC). We assessed anaplastic lymphoma kinase (ALK) testing rates and factors related to underuse in community m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Bernicker, Eric H., Xiao, Yan, Abraham, Anup, Yang, Baiyu, Croix, Denise A., Redpath, Stella, Engstrom‐Melnyk, Julia, Shah, Roma, Madala, Jaya, Allen, Timothy C.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176985/
https://ncbi.nlm.nih.gov/pubmed/33823082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13779
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!